Our clinical data indicated that lncRNA BC087858 expression levels were significantly higher in EGFR-mutant NSCLC patients who developed acquired resistance to EGFR-TKIs compared with before treatment levels. Here, EGFR is linked to non-small cell lung carcinoma.